Trial Profile

Clinical Phase I/IIA Study of Subcutaneous Administration of Ofatumumab in Rheumatoid Arthritis Patients on Stable Dose Methotrexate.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ofatumumab (Primary)
Indications Rheumatoid arthritis
Focus Adverse reactions
Sponsors GlaxoSmithKline; GSK

Most Recent Events

01 Jun 2013 Results published in The Journal of Rheumatology.
24 Mar 2012 This trial has been recruiting in France and Spain.
28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com